CLINICAL VALUE OF SUPAR, A NEW BIOMARKER

被引：0
|
作者：
Donadello, K. [1 ]
Covajes, C. [1 ]
Scolletta, S. [1 ]
Taccone, F. S. [1 ]
Santonocito, C. [1 ]
Brimioulle, S. [1 ]
Beumier, M. [1 ]
Van Nuffelen, M. [1 ]
Gottin, L. [2 ]
Vincent, J-L [1 ]
机构：
[1] Erasme Univ Hosp, B-1070 Brussels, Belgium
[2] Policlin Univ GB Rossi, Verona, Italy
来源：
INTENSIVE CARE MEDICINE | 2011年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
0775
引用
收藏
页码：S199 / S199
页数：1
相关论文
共 50 条
  • [31] Evaluation of the diagnostic and prognostic potential of the novel inflammatory biomarker suPAR in pleural effusion
    Matzkies, L.
    Flick, H.
    Rabensteiner, J.
    Feierl, G.
    Hoenigl, M.
    Raggam, R.
    Prattes, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S387 - S387
  • [32] SERUM SUPAR DETERMINATIONS AS DIAGNOSTIC BIOMARKER OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS - A RETROSPECTIVE ANALYSIS
    Verdelho, Miguel
    Ferreira, Carina
    Gois, Mario
    Santos, Maria Ceu
    Viana, Helena
    Carvalho, Fernanda
    Ribeiro, Francisco
    Nolasco, Fernando
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 388 - 389
  • [33] Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
    Rasmussen, Line Jee Hartmann
    Petersen, Jens Emil Vang
    Eugen-Olsen, Jesper
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [34] HDL functionality as a new possible clinical biomarker
    Favari, E.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 39 - 40
  • [35] PROGNOSTIC VALUE OF SUPAR IN SEVERE SEPSIS AND SEPTIC SHOCK PATIENTS
    Suberviola, B.
    Castellanos-Ortega, A.
    Iglesias, D.
    Suarez, V.
    Ortiz-Melon, F.
    Marcos, L. -H.
    INTENSIVE CARE MEDICINE, 2012, 38 : S99 - S99
  • [36] Nanomechanical recognition of prognostic biomarker suPAR with DVD-ROM optical technology
    Bache, Michael
    Bosco, Filippo G.
    Brogger, Anna L.
    Frohling, Kasper B.
    Alstrom, Tommy Sonne
    Hwu, En-Te
    Chen, Ching-Hsiu
    Eugen-Olsen, Jesper
    Hwang, Ing-Shouh
    Boisen, Anja
    NANOTECHNOLOGY, 2013, 24 (44)
  • [37] Soluble urokinase-type plasminogen activator receptor (suPAR) as new biomarker of the prosthetic joint infection: Correlation with inflammatory cytokines
    Galliera, Emanuela
    Drago, Lorenzo
    Marazzi, Monica Gioia
    Romano, Carlo
    Vassena, Christian
    Romanelli, Massimiliano M. Corsi
    CLINICA CHIMICA ACTA, 2015, 441 : 23 - 28
  • [38] The clinical value of suPAR in diagnosis and prediction for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
    Huang, Qiangru
    Xiong, Huaiyu
    Shuai, Tiankui
    Wang, Yalei
    Zhang, Chuchu
    Zhang, Meng
    Zhu, Lei
    Lu, Jiaju
    Liu, Jian
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [39] Reply: Measurement of serum suPAR is not ready for clinical use
    Deegens, Jeroen
    Wetzels, Jack
    NATURE REVIEWS NEPHROLOGY, 2014, 10 (10) : 610 - 610
  • [40] Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker
    Zhang, Xuehui
    Li, Hui
    Yu, Xiuyan
    Li, Shanxin
    Lei, Zhen
    Li, Chang
    Zhang, Qun
    Han, Qing
    Li, Yuan
    Zhang, Kun
    Wang, Yuxiang
    Liu, Congrong
    Mao, Yiqing
    Wang, Xi
    Irwin, David M.
    Guo, Hongyan
    Niu, Gang
    Tan, Huanran
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 48 (05) : 1983 - 1994
12345